Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 40 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2010Rationale and design of the Endurant Stent Graft Natural Selection Global Postmarket Registry (ENGAGE): interim analysis at 30 days of the first 180 patients enrolledBockler, D.; Fitridge, R.; Wolf, Y.; Hayes, P.; Silveira, P.; Numan, F.; Riambau, V.
2016Young-onset colorectal cancer in New South Wales: a population-based studyBoyce, S.; Nassar, N.; Lee, C.; Suen, M.; Zahrani, S.; Gladman, M.
2014Time to breast cancer relapse predicted by primary tumour characteristics, not lymph node involvementFitzpatrick, D.; Lai, C.; Parkyn, R.; Walters, D.; Humeniuk, V.; Walsh, D.
2018Association between the EPHX2 p.Lys55Arg polymorphism and prognosis following an acute coronary syndromeOni-Orisan, A.; Cresci, S.; Jones, P.G.; Theken, K.N.; Spertus, J.A.; Lee, C.R.
2014IGFBP7 is associated with poor prognosis in oesophageal adenocarcinoma and is regulated by promoter DNA methylationSmith, E.; Ruszkiewicz, A.; Jamieson, G.; Drew, P.
2015Randomized phase II study of carboplatin and paclitaxel with either linifanib or placebo for advanced nonsquamous non–small-cell lung cancerRamalingam, S.S.; Shtivelband, M.; Soo, R.A.; Barrios, C.H.; Makhson, A.; Segalla, J.G.; Pittman, K.B.; Kolman, P.; Pereira, J.R.; Srkalovic, G.; Belani, C.P.; Axelrod, R.; Owonikoko, T.K.; Qin, Q.; Qian, J.; McKeegan, E.M.; Devanarayan, V.; McKee, M.D.; Ricker, J.L.; Carlson, D.M.; et al.
2016Choline kinase alpha as an androgen receptor chaperone and prostate cancer therapeutic targetAsim, M.; Massie, C.; Orafidiya, F.; Pértega-Gomes, N.; Warren, A.; Esmaeili, M.; Selth, L.; Zecchini, H.; Luko, K.; Qureshi, A.; Baridi, A.; Menon, S.; Madhu, B.; Escriu, C.; Lyons, S.; Vowler, S.; Zecchini, V.; Shaw, G.; Hessenkemper, W.; Russell, R.; et al.
2014Survival of Australian women with invasive epithelial ovarian cancer: a population-based studyAnuradha, S.; Webb, P.; Blomfield, P.; Brand, A.; Friedlander, M.; Leung, Y.; Obermair, A.; Oehler, M.; Quinn, M.; Steer, C.; Jordan, S.
2013Phase III randomized, placebo-controlled study of cetuximab plus brivanib alaninate versus cetuximab plus placebo in patients with metastatic, chemotherapy-refractory, wild-type K-RAS colorectal carcinoma: The NCIC clinical trials group and AGITG co.Siu, L.; Shapiro, J.; Jonker, D.; Karapetis, C.; Zalcberg, J.; Simes, J.; Couture, F.; Moore, M.; Price, T.; Siddiqui, J.; Nott, L.; Charpentier, D.; Liauw, W.; Sawyer, M.; Jefford, M.; Magoski, N.; Haydon, A.; Walters, I.; Ringash, J.; Tu, D.; et al.
2011Impact of ineffective oesophageal motility and wrap type on dysphagia after laparoscopic fundoplicationBroeders, J.; Sportel, I.; Jamieson, G.; Nijjar, R.; Granchi, N.; Myers, J.; Thompson, S.